Oral Solid Dose CDMOs

Ethypharm

China

Ethypharm is a leading mid-size international specialty pharmaceutical company and CDMO with 5 manufacturing plants across France, UK, and Spain. The company specializes in oral solid dosage forms, sterile injectables in ampoules, pre-filled syringes and IV bags, with particular expertise in high potent APIs and controlled substances including opioids and psychotropics.

Gracure Pharmaceuticals Ltd

India

Gracure Pharmaceuticals Ltd is an Indian pharmaceutical company offering contract development and manufacturing services for finished dosage forms. The company manufactures oral solid dosage forms, liquids, and semi-solid products from WHO GMP and EU GMP-certified facilities, serving regulated and semi-regulated export markets. It provides formulation development, analytical testing, and commercial-scale manufacturing.

Gufic Biosciences Ltd

India

Gufic Biosciences Ltd is an Indian pharmaceutical company established in 1970, recognized as one of the largest manufacturers of lyophilized injections in India. The company operates a fully automated lyophilization plant and offers CMO/CDMO services for lyophilized injectables across antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments.

Hanmi Pharm. Co. Ltd

South Korea

Hanmi Pharmaceutical is a major South Korean pharmaceutical company providing comprehensive CDMO services across the entire pharmaceutical lifecycle. The company operates through Paltan Smart Plant (producing 6+ billion chemical drug tablets annually), Pyeongtaek Bioplant (FDA-approved biopharmaceutical manufacturing with 12,500L bioreactors), and Hanmi Fine Chemical (API and raw materials including mRNA cap analogs, NTP, and lipids). Hanmi has partnerships with global pharma companies including Lilly, Roche, and Sanofi.

Harman Finochem Ltd

India

Harman Finochem Ltd is an India-based CDMO/CMO specializing in the manufacture and export of Active Pharmaceutical Ingredients, with core competencies in Metformin HCl, Fenofibrate, Divalproex Sodium, and over 45 other APIs. The company also operates a finished dosage form facility with EU GMP approval, capable of producing 2 billion tablets per year.

Health Biotech Limited

India

Health Biotech Limited is an Indian pharmaceutical manufacturer and exporter specializing in finished dosage forms across multiple formats including tablets, capsules, nasal sprays, ointments, creams, and liquid orals. The company serves global markets and provides contract manufacturing services.

Hebei Veyong Pharmaceutical Co.,Ltd.

China

Hebei Veyong Pharmaceutical Co., Ltd. is a large GMP-certified Chinese veterinary pharmaceutical enterprise specializing in the R&D, production, and sales of veterinary APIs and preparations. Key products include Ivermectin, Eprinomectin, Tiamulin Fumarate, and Oxytetracycline, with production bases in Shijiazhuang and Ordos.

Hennig Arzneimittel GmbH & Co. KG

Germany

Hennig Arzneimittel GmbH & Co. KG is a German family-owned pharmaceutical company with over 120 years of experience, based in Floersheim am Main near Frankfurt. The company operates as both a branded pharmaceutical manufacturer and CDMO, specializing in solid dosage forms including sustained-release tablets, pellets, granules, and capsules. Acquired by Italian company Polifarma S.p.A. in January 2025.

Hikma Pharmaceuticals

Algeria

Hikma Pharmaceuticals is a global pharmaceutical company with 29 manufacturing plants across the US, Europe, and MENA, producing injectable, oral, and respiratory medicines. The company offers CMO services and has announced a $1 billion investment by 2030 to expand US manufacturing and R&D capabilities. Hikma has 76 FDA-approved products, produces 500 million injectable units annually, and has maintained zero critical FDA observations in 20+ years.

Hiral Labs Ltd

India

Hiral Labs Ltd is an Indian pharmaceutical contract manufacturer established in 2000, based near Roorkee, Uttarakhand. The company operates two WHO-GMP and ISO-certified manufacturing sites producing liquid injections, tablets, capsules, ointments, syrups, eye/ear drops, and oncology injections (including lyophilized). Hiral Labs manufactures over 350 formulations on a contractual basis for more than 300 companies across approximately 4,000 brands.

Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

China

Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (branded as HY Pharma / Zhejiang Hongyuan Pharmaceutical) is a Chinese pharmaceutical company established in 2005, now a subsidiary of the Wuchan Zhongda Group (Fortune 500). The company focuses on cardiovascular and hypoglycemic drug substance, API, and finished dosage form development and manufacturing, with 21+ invention patents.

Humanwell Healthcare (Group) Co.,Ltd

China

Humanwell Healthcare (Group) Co., Ltd is a Chinese pharmaceutical company headquartered in Yichang that develops and manufactures medicines and pharmaceutical products. The company has FDA-registered facilities and approved products including capsules and tablets for oral administration.

Iasis Pharma S.A.

Greece

Iasis Pharma S.A. is a steadily growing Greek pharmaceutical company founded in Athens, engaged in the manufacture and marketing of a wide range of pharmaceutical products across multiple therapeutic areas. The company operates production facilities and offers products including oral solids, injectables, and topicals.

IBSA Institut Biochimique SA

Italy

IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical company founded in 1945 in Lugano, with products present in over 90 countries. The company develops and manufactures innovative pharmaceutical products across 10 therapeutic areas with proprietary drug delivery technologies, including oral films, patches, and gonadotropin purification processes. IBSA has FDA-approved products in multiple dosage forms.

Innova Captab Ltd

India

Innova Captab Ltd is the second largest domestic formulations CDMO in India, providing contract development and manufacturing services across tablets, capsules, dry syrups, ointments, liquid orals, and dry powder injections. The company operates five state-of-the-art facilities with nine independent manufacturing blocks in Baddi, Dehradun, Taloja, and Kathua, serving 14 of the top 15 Indian pharmaceutical companies.

Insud Pharma

Argentina

Insud Pharma is a large, diversified Spanish multinational pharmaceutical group with over 45 years of experience, 10,000 professionals, and 20 industrial plants across more than 50 countries. The company operates API manufacturing, oral solid dose, and injectable manufacturing through its CMO division (Chemo CMO), and biologics/biosimilar manufacturing through its biotech unit mAbxience (majority stake sold to Fresenius Kabi in 2022).

Intas Pharmaceuticals

India

Intas Pharmaceuticals is a leading vertically integrated pharmaceutical company headquartered in Ahmedabad, India, with CDMO capabilities spanning API manufacturing through finished formulations. The company operates 14 manufacturing facilities globally (11 in India, plus UK and Mexico), serving 85+ countries with particular strength in oncology, biosimilars, and plasma-derived therapies. Its flagship Pharmez 2 facility can produce over 1 billion solid oral units monthly and 5 million injectable units.

JAMP Pharma

Canada

JAMP Pharma Group is a leading Canadian pharmaceutical company with over 35 years in the industry, active across generic drugs (JAMP Pharma), biosimilars (BioJAMP), branded products (Orimed Pharma), natural health products (Wampole/Laboratoire Suisse), and beauty products (Cosmetic Import). The company acquired a pharmaceutical manufacturing facility in Levis, Quebec, and manufactures prescription drugs in Canada through its JAMP Pharma Manufacturing division.

JCR Pharmaceuticals

Japan

JCR Pharmaceuticals is a Japanese pharmaceutical company and CDMO founded in 1975, with nearly 50 years of experience in rare disease treatments and orphan drug production. Selected for Japan's Regenerative Medicine CDMO Subsidy Program in 2025, the company is expanding biomanufacturing infrastructure for cell, gene, and regenerative medicine therapies. JCR operates five production sites and has proprietary platforms including JUST-AAV for gene therapy and J-Brain Cargo for blood-brain barrier penetration.

Jeil Pharmaceutical Co., Ltd.

South Korea

Jeil Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company headquartered in Seoul that offers APIs, finished dosage products, and CMO services. The company has a production capacity of 1.5 billion oral dosage units per year and manufactures tablets, transdermal patches, and other dosage forms. Jeil supplies 62 products including APIs, excipients, and intermediates and is FDA-registered.

Jerome Stevens Pharmaceuticals, Inc.

United States

Jerome Stevens Pharmaceuticals, Inc. (JSP) is a family-owned pharmaceutical manufacturer based in Bohemia, New York, established in 1979. The company specializes in manufacturing prescription tablet and capsule formulations under cGMP standards. JSP is notable for manufacturing UNITHROID, the first FDA-approved Levothyroxine Sodium product, and also produces Digoxin tablets. The company provides CMO services to partners including Amneal Pharmaceuticals.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

China

Jiangsu Nhwa Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company specializing in CNS (Central Nervous System) drugs, listed on Shenzhen Stock Exchange (002262.SZ) since 2008. Founded in 1978, the company is designated as a national production unit for narcotic and psychotropic drugs. Nhwa operates over 10 automated production lines for tablets, capsules, liquid injectables, and powder injectables, covering over 800 acres. The company serves as a major global CNS drug production and R&D base.

Life Pharma FZE

United Arab Emirates

Life Pharma FZE (LIFEPharma) is a UAE-based pharmaceutical manufacturer and the only USFDA-approved pharmaceutical company in the United Arab Emirates. Part of VPS Healthcare, the company manufactures a wide range of generic finished dosage forms including tablets, capsules, and liquid oral preparations at its facility in Jebel Ali, Dubai. LIFEPharma is building a new oncology manufacturing facility in Abu Dhabi.

Lomapharm GmbH

Germany

Lomapharm GmbH is a German pharmaceutical contract manufacturer with 140+ years of experience (since 1878), offering services from development through production and packaging to market release. The company produces solid oral dosage forms (including micro-tablets) and aseptically manufactured sterile dosage forms such as preservative-free eye drops and nasal sprays. Lomapharm was formerly a subsidiary of Daicel Corporation before being transferred to Bionorica SE.

Medichem S.A.

Malta

Medichem S.A. is a family-owned, vertically integrated pharmaceutical company headquartered in Barcelona, Spain, with nearly 50 years of industry experience. The company delivers end-to-end solutions from API development to finished drug product manufacturing (oral and injectable). Their portfolio includes approximately 45 APIs and 20 finished dosage forms (FDF), supported by full regulatory dossiers. Medichem provides API and FDF CDMO solutions and is also a leader in antiseptic products. The company has 400 experienced professionals serving 600+ corporate customers across 60+ countries. Facilities include R&D centres in Barcelona, Celra, and Hal-Far (Malta), and manufacturing plants in Celra (Spain), Hal-Far (Malta), and a new sterile injectables facility in Llanera, Asturias (Medichem Solutions). Medichem also has commercial offices in New York and Nanjing.

Milan Laboratories (India) Pvt. Ltd.

India

Milan Laboratories (India) Pvt. Ltd. is an Indian pharmaceutical manufacturer and exporter established in 1976, producing and exporting pharmaceutical formulations from WHO-cGMP compliant facilities. The company has 300+ marketing authorizations across 43+ countries. Milan has 9 FDA-registered FEI numbers, 65 FDA-approved products across multiple dosage forms (tablets, injectables, liposomal injectables, solutions, emulsions, powders), and has received 38 FDA inspections (14 NAI, 19 VAI, 5 OAI). The company has also had 16 Class II recalls. Milan provides regulatory consulting services and dossier preparation in ACTD, CTD, eCTD formats.

MSN Laboratories

India

MSN Laboratories is a Hyderabad-based major pharmaceutical CDMO with $1.2 billion in revenue. The company operates 15 API facilities and 6 finished dosage form (FDF) facilities across India and the USA (Novadoz Pharmaceuticals). MSN offers CRAMS (Contract Research and Manufacturing Services) with 200+ first-to-market generics and 400+ formulations. Specialized capabilities include cytotoxics, high-potency APIs, peptides, prostaglandins, and biosimilars. FDA-registered with 14 FEI numbers, 31 FDA inspections (16 NAI, 15 VAI — strong track record), and 119 FDA-approved products. Has established an advanced E&L (Extractables and Leachables) Laboratory.

NerPharMa srl (NMS Group)

Italy

NerPharMa is an Italian CDMO (part of NMS Group, acquired by Benta in 2026) specializing in highly potent compounds with strong expertise in oncology. It operates two divisions: Drug Substance (API manufacturing in high containment glove-box suites, 50-250L reactors, 0.5-5 kg batches) and Drug Product (injectable solutions, suspensions, lyophilized products, and oral solid dosage forms including cytotoxic and cytostatic products).

Nobel Ilac Sanayii Ve Ticaret A.S.

Kazakhstan

Nobel Ilac is a Turkish pharmaceutical company founded in 1964, operating in 20+ countries with representative offices and exporting drug substances and drug products to over 50 countries. The company manufactures both APIs and finished dosage forms, with biotechnology as a declared strategic priority. It is listed as a CMO/CDMO on PharmaSource with contract small molecule API manufacturing capabilities.

Normon

Spain

Laboratorios Normon is a Spanish pharmaceutical company manufacturing generic medicines. Founded as a family company, it has invested over 100 million euros in expansion and operates FDA-registered manufacturing facilities. The company is listed as a CMO/CDMO on PharmaSource and appears in cytotoxic drugs and HPAPI manufacturing market reports, indicating high-potency capabilities.

Novartis Contract Manufacturing

Austria

Novartis Contract Manufacturing is the CDMO arm of Novartis, offering fully integrated end-to-end manufacturing solutions across biologics (mammalian up to 15,000L, microbial up to 13,000L), small molecules (API to fill & finish), cell & gene therapy (CAR-T, AAV, LV), xRNA/LNP/pDNA, and comprehensive fill & finish services. The operation spans multiple state-of-the-art facilities across Austria, Switzerland, Slovenia, Belgium, France, Singapore, and the United States, with 107 FDA inspections and 27 FEI registrations.

Novell Pharmaceutical Laboratories

Indonesia

Novell Pharmaceutical Laboratories is one of the largest pharmaceutical companies in Indonesia, manufacturing both oral solid dosage forms (tablets, capsules, powders) and sterile injectable products (liquid and powder). The factory was originally built and operated by a multinational company, and later expanded to Australian TGA standards. The facility features Class A/B/C/D cleanrooms, Bausch & Stroebel filling equipment, Getinge autoclaves, and Lytzen depyrogenation ovens. Novell has 2 FDA-registered FEI numbers, 3 FDA-approved products, and 10 FDA inspections.

Novugen Pharma

Malaysia

Novugen Pharma is a Malaysian pharmaceutical company and CDMO subsidiary of UAE-based SciTech International, providing vertically integrated API and finished dosage form development and manufacturing. The company has USFDA-approved facilities including a dedicated oncology manufacturing plant. Novugen achieved zero Form 483 citations from USFDA and holds Halal pharmaceutical certification.

Orofino Pharmaceuticals Group

Italy

Orofino Pharmaceuticals Group (OPG), headquartered in Rome, Italy, is a group of companies specializing in third-party pharmaceutical manufacturing services. The group includes Biopharma (betalactam finished products), Injectalia (small sterile liquids including hormones, biologicals, heparins, vaccines), K24 Pharmaceuticals (chemical testing, EU release, secondary packaging), and Drug'On Pharma Switzerland (API manufacturing). Focused on sterile injectables and betalactam oral/injectable dosage forms.

PannonPharma Ltd

Hungary

PannonPharma Ltd is a Hungarian pharmaceutical company based in Pecsvarad, manufacturing pharmaceuticals since 1995. The company produces solid dosage forms (tablets, film-coated tablets, hard gelatin capsules, modified-release tablets), as well as topical products (gels, sprays) and inhalation drops. Products include Diapulmon inhalation drops, Phlogosol antiseptic solution, Ebrimycin antibiotic gel, IRIX spray, and Thaleum allergy eye drops/nasal spray. Offers contract manufacturing services alongside its own product portfolio. GMP certified.

PCI Pharma Services

Australia

PCI Pharma Services is a global CDMO providing fully integrated drug development, manufacturing, clinical trial services, and commercial packaging solutions. With over 8,000 employees in 38 GMP facilities worldwide, PCI offers services spanning sterile fill-finish, lyophilization, oral solid dose manufacturing, complex formulations, and advanced drug delivery including drug-device combination products.

Pell Tech Healthcare Pvt. Ltd.

India

Pelltech Healthcare is a privately owned WHO-GMP approved Indian pharmaceutical company specializing in the manufacture of conventional and modified-release pellets and finished formulations in capsules and tablets. The company has a dedicated state-of-the-art manufacturing facility focused on pellet-based oral solid dosage forms, taking APIs through formulation development to commercial production.

PENMIX Co. Ltd.

South Korea

PENMIX is Korea's largest CDMO, fully committed to globalization of the pharmaceutical industry. The company operates dedicated penicillin manufacturing and general injection manufacturing plants with KGMP and FDA registration. PENMIX provides contract manufacturing services for penicillin formulations (tablets, injections) and sterile injectable products including lyophilized vials, liquid vials, ampoules, and pre-filled syringes, with full automation lines conforming to PICS GMP guidelines.

Pen Tsao Chemical Industry Ltd

China

Pen Tsao Chemical Industry Ltd is a back-integrated manufacturer of APIs, advanced pharma intermediates, and oral solid dosage formulations based in Shanghai, China with over 25 years of experience. The company produces 30+ APIs and formulations from two facilities: a multipurpose plant in Baoshan (56 m3 reactor volume, 218 m3 at Jinshan) and a new site in Pinghu with 270 tons API capacity and 70 tons OSD capacity. Pen Tsao was the first WHO pre-qualified supplier of MDR-tuberculosis drugs.

Pfizer CentreOne

Belgium

Pfizer CentreOne is a global CDMO embedded within Pfizer, specializing in commercial manufacturing of oral solid doses, sterile injectables, biologics including monoclonal antibodies, and antibody-drug conjugates. It leverages Pfizer's global manufacturing network across six continents with cGMP-compliant sites and over 170 years of pharmaceutical manufacturing expertise, backed by $1B+ annual manufacturing investments.

Pharco Corporation

Egypt

Pharco Corporation is the largest pharmaceutical manufacturer in Egypt and the MENA region, comprising 11 companies focused on development, manufacturing, marketing, and distribution of generics and branded generics. The company produces 2.5 million packs daily, exports to 50+ countries, and operates an API manufacturing subsidiary (PBIC) with custom synthesis contracts. Pharco is WHO-prequalified for HCV medicines.

Pharma 5

Morocco

Pharma 5 is a Moroccan pharmaceutical company specializing in the development, manufacturing, and commercialization of pharmaceutical products. The company is the first supplier of tuberculosis treatments in Morocco and developed the first Moroccan anti-Hepatitis C medication. It operates a Smart Factory and holds ISO 9001 certification and Saudi FDA homologation.

Pharmaniaga Manufacturing Berhad

Malaysia

Pharmaniaga Manufacturing Berhad is a Malaysian pharmaceutical manufacturer and CDMO offering contract manufacturing services. The company produces oral solid dosages (7 billion tablets/capsules capacity), liquids (2.9 million bottles), creams (5 million tubes), small volume injectables including ampoules/vials (43 million units), pre-filled syringes and insulin cartridges (25 million units each), and dry syrups. Products include general pharmaceuticals, penicillin, cephalosporin, and OTC products. Facilities are designed to international pharmaceutical engineering guidelines.

Pharmascience

Canada

Pharmascience is Canada's largest privately-owned pharmaceutical company, a leading manufacturer of generic, branded, and over-the-counter pharmaceuticals. The company has recently expanded its CDMO services with a new commercial business unit, investing over $120 million to expand its sterile injectable manufacturing facility in Candiac, Quebec, aiming to more than triple capacity. Pharmascience's ambition is to become a world leader in the sterile injectable CDMO segment. The company distributes products in over 50 countries and invests approximately $65 million per year in R&D in Canada. The Pendopharm division offers specialty medicines in gastroenterology, orthopedics, and neurology.

Pharma Tech Industries

United States

Pharma Tech Industries (PTI) is a pharmaceutical CDMO specializing exclusively in non-sterile dry powder blending and high-speed packaging. Founded in 1972, the company operates multiple FDA-registered, NSF-compliant, climate-controlled facilities in Georgia and Missouri under strict cGMP standards. PTI provides development to high-volume commercial-scale production for pharmaceutical, OTC drug & personal care, and nutritional health & medical foods. Delivery formats include sachets, stick packs, bottles, pouches, effervescents, tablets, capsules, drug-devices, and medical swabs. The company has onsite GMP analytical/microbiology labs and uses quality systems including Empower, eQMS, EDMS, and ERP Serialization. PTI earned the highest possible score in the 2024 CDP SME environmental evaluation.

Pharmathen

Greece

Pharmathen is a Greek research-centred CDMO specializing in complex drug delivery and formulation development. Founded in 1969 and acquired by Partners Group for $1.89 billion, the company operates two state-of-the-art manufacturing facilities: Rodopi (FDA-approved, 15,300 m2, capacity 3.3 billion tablets, 1.2 billion capsules, 175 million blisters, 4 million sterile syringes/vials) and Pallini/Attica (4,000 m2, 800 million tablets/capsules, 1.5 million sterile vials, 6 million ampoules). Pharmathen has also acquired CBL Patras. Key technology platforms include Long Acting Injectables (biodegradable microparticles, nanosuspensions, self-assembled nanogel systems), modified release oral formulations, preservative-free ophthalmic formulations, and solubility/permeability enhancement technologies.

Pharmazeutische Fabrik Montavit GmbH

Austria

Pharmazeutische Fabrik Montavit GmbH is an Austrian family-owned pharmaceutical company founded in 1945 in Absam, Tyrol. The company researches, develops, and manufactures pharmaceutical products and medical devices, exporting to over 80 countries. Montavit offers contract manufacturing (Lohnherstellung/Auftragsfertigung) services to other pharmaceutical companies. Dosage forms include tablets, film-coated tablets, dragees, liquids, creams/gels, granulates, suppositories, sterile pre-filled syringes, laminate tubes, sterile blisters, and powders. The company's own product portfolio covers urology, gynecology, allergy, sleep, travel health, and herbal medicines, with the wound care product Acerbine being well-known.

Phlow Corporation

United States

Phlow Corporation is a U.S.-based public-benefit pharmaceutical manufacturer specializing in onshore continuous-flow production of medicines and APIs. The company was awarded a landmark $354 million HHS/ASPR/BARDA contract to manufacture essential medicines in shortage, strengthening America's pharmaceutical supply chain. Phlow has raised $37 million in Series C funding to expand U.S.-based CDMO operations. The company partners with Fresenius Kabi for the first-ever end-to-end U.S. manufacturing of Epinephrine Injection USP, with Antheia for advanced manufacturing technologies, and with USP for pharmaceutical continuous manufacturing. Phlow is driving sustainable cost competitiveness through advanced manufacturing technology including continuous flow chemistry and AI-enhanced analytics.